VKH
CORT icon

Virtu KCG Holdings’s Corcept Therapeutics CORT Stock Holding History

Virtu KCG Holdings’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-102,730
Closed -$746K – 3196
2016
Q4 		$746K Buy
102,730
+73,189
+248% +$573K 0.02% 1035
2016
Q3 		$192K Buy
29,541
+16,058
+119% +$93.4K ﹤0.01% 2382
2016
Q2 		$74K Buy
+13,483
New +$70.1K ﹤0.01% 2598
2015
Q3 		– Sell
-12,778
Closed -$77K – 3397
2015
Q2 		$77K Buy
+12,778
New +$78.3K ﹤0.01% 2987
2013
Q4 		– Sell
-11,658
Closed -$19K – 3829
2013
Q3 		$19K Buy
+11,658
New +$20.6K ﹤0.01% 3619

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Virtu KCG Holdings's CORT Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Corcept Therapeutics (CORT) in Q1 2017, closing a stake of 102,730 shares — an estimated $746K sold.

Virtu KCG Holdings first reported a position in CORT in Q3 2013 and held it in 5 quarters. The position peaked at $746K in Q4 2016. 135 funds tracked by Wall St. Rank hold CORT as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Corcept Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 102,730 Corcept Therapeutics shares in Q1 2017, an estimated $746K.
  • Virtu KCG Holdings first reported a position in Corcept Therapeutics in Q3 2013 and held it in 5 quarters.
  • Virtu KCG Holdings's Corcept Therapeutics position peaked at $746K in Q4 2016.
  • 135 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.